EDGAR Filing Documents for 0001415889-16-005383

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001415889-16-005383

Filing Date

2016-03-30

Accepted

2016-03-30 16:32:50

Documents

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	ecte10k_dec312015.htm	10-K	1264776
2	SUBSIDIARIES OF THE COMPANY.	ex21-1.htm	EX-21.1	2706
3	CONSENT OF BDO USA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	ex23-1.htm	EX-23.1	2577
4	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 (A) UNDER T	ex31-1.htm	EX-31.1	8807
5	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14 (A) UNDER T	ex31-2.htm	EX-31.2	9148
6	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,	ex32-1.htm	EX-32.1	4524
7	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,	ex32-2.htm	EX-32.2	4955
	Complete submission text file	0001415889-16-005383.txt		4242043

Data Files

Seq	Document	Type	Size
8	ecte-20151231.xml	EX-101.INS	544627
9	ecte-20151231.xsd	EX-101.SCH	59020
10	ecte-20151231_cal.xml	EX-101.CAL	52596
11	ecte-20151231_def.xml	EX-101.DEF	135867
12	ecte-20151231_lab.xml	EX-101.LAB	374401
13	ecte-20151231_pre.xml	EX-101.PRE	266992

Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830

Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)